CompletedNot Applicable

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

220 participantsStarted 2012-01-03

Plain-language summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and lean more about biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in blood samples from patients with acute myeloid leukemia.

Who can participate

Age range

17 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Morphologically confirmed acute myeloid leukemia (AML) * Newly diagnosed with AML * Serum samples from patients enrolled on the ECOG-1900 clinical trial between 2002 and 2008 * Patients with or without isocitrate dehydrogenase (IDH) mutations PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Received 2 different doses of standard induction chemotherapy on ECOG-1900

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Absence of serum 2HG in all samples without an IDH mutation

Timeframe: 1 day

Trial details

NCT IDNCT01385150

SponsorEastern Cooperative Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2012-02-03

View on ClinicalTrials.gov More Leukemia trials

Who can participate

Age range

17 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.